Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BBOX1 | O75936 | 7/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SLC22A16 | Q86VW1 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10410042 | 0.79 | BBOX1 (0.38) | BBOX1MEN1CYP2C19RECQLKMT2A | |
| SCHEMBL15157011 | 0.79 | BBOX1 (0.39) | BBOX1SLC22A16CA2 | |
| SCHEMBL10641701 | 0.77 | BBOX1 (0.46) | BBOX1 | |
| SCHEMBL2229655 | 0.77 | BBOX1 (0.46) | BBOX1MEN1KMT2A | |
| SCHEMBL10643640 | 0.77 | BBOX1 (0.35) | BBOX1SLC22A16 | |
| SCHEMBL643573 | 0.75 | TSHR (0.31) | — | |
| SCHEMBL20972162 | 0.74 | POLB (0.33) | BBOX1 | |
| Tetrylammonium SCHEMBL7572283 | 0.74 | TSHR (0.44) | BBOX1 | |
| Tetramethylammonium Ion SCHEMBL715918 | 0.72 | ALDH1A1 (0.41) | BBOX1SLC22A16 | |
| SCHEMBL17438922 | 0.72 | ALDH1A1 (0.41) | CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040222401-A1 | Electrochemically stable onium salts and electrolytes containing such for electrochemical capacitors | XU KANG (US) | 2004-11-11 | — | — | US | disclosed |
| US-6743947-B1 | HAVING ASYMMETRIC SUBSTITUTION ON CATION; ALTERING MELTING POINT AND SOLUBILITY | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY | 2004-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040222401-A1 | Electrochemically stable onium salts and electrolytes containing such for electrochemical capacitors | VDAC2, VDAC1, HCN2 | BBOX1 1644/4885MEN1 2459/4885CYP2C19 3063/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.